Dr. Choi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5230 Centre Avenue
Pittsburgh, PA 15232Phone+1 412-623-6720
Summary
- Dr. Serah Choi is a radiation oncologist in Pittsburgh, PA and is affiliated with multiple hospitals in the area, including UPMC Presbyterian Shadyside, UPMC Children's Hospital of Pittsburgh, UPMC Magee-Womens Hospital, UPMC St. Margaret, UPMC Mercy, and UPMC Passavant. She received her MD and PhD from University of Pittsburgh Medical Scientist Training Program and has been in practice for six years. She specializes in central nervous system cancer radiation oncology and stereotactic radiosurgery.
Education & Training
- University of California (San Francisco)Residency, Radiation Oncology, 2014 - 2018
- UPMC Medical EducationInternship, Transitional Year, 2013 - 2014
- University of Pittsburgh School of MedicineClass of 2013
Certifications & Licensure
- OH State Medical License 2018 - 2025
- PA State Medical License 2023 - 2024
- CA State Medical License 2015 - 2019
- American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Clinical and Genetic Markers of Vascular Toxicity in Glioblastoma Patients: Insights from NRG Oncology RTOG-0825.Joshua D Strauss, Mark R Gilbert, Minesh Mehta, Ang Li, Renke Zhou Ms
Neuro-Oncology. 2024-11-16 - NRG-BN002: Phase I study of ipilimumab, nivolumab, and the combination in patients with newly diagnosed glioblastoma.Andrew E Sloan, Kathryn Winter, Mark R Gilbert, Kenneth Aldape, Serah Choi
Neuro-Oncology. 2024-09-05 - Outcomes of initial therapy for synchronous brain metastases from small cell lung cancer: a single-institution retrospective analysis.Kevin V Chaung, Michael Z Kharouta, Andrew J Gross, Pingfu Fu, Mitchell Machtay
Translational Lung Cancer Research. 2024-05-31
Press Mentions
- Refining Complex Re‐Irradiation Dosimetry Through Feasibility Benchmarking and Analysis for Informed Treatment PlanningDecember 3rd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: